Our findings indicate that in experimental ischemic stroke with reperfusion, the duration of ischemia and r-tPA treatment significantly impacts the expression of MMP-2, MMP-3, and MMP-9, as well as the extent of ischemic brain injury and neurological outcomes. This evidence concerns the gene PLAT and ischemic stroke.